Marco Bongiovanni

18PUBLICATIONS
12CO-AUTHORS
Epidemiological modellingNanotoxicology, health and safetySpeciation and extinctionPeripheral nervous systemMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 04, 2026
Severe invasive pneumococcal disease beyond current vaccination recommendations: implications for higher-valency vaccines.

|Jul 25, 2026
Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.

|Apr 20, 2026
Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial.

|Feb 27, 2026
Human Prion Disease: Pathogenesis, Diagnosis and Public Health.

Paola Bellini, Francesco Ruggiero, Andrea Benedetti

|Feb 27, 2026
From Respiratory Pathogen to Systemic Threat: Rethinking Mycoplasma pneumoniae Infections.

Marco Bongiovanni

|Feb 27, 2026
Oritavancin for Gram-Positive Bone and Joint Infections: A Comprehensive Review of the Literature.

Zain Ahmed Raza, Alex Giannini, Marco Bongiovanni

Pageof 3

Frequent Collaborators

1 joint publications

Enos Bernasconi

1 joint publications

Alex Giannini

1 joint publications

Francesco Ruggiero

1 joint publications

Natalie Rose